Study in human cells shows it counteracts Ebola’s defenses
Amid the worsening Ebola outbreak in the Congo, now threatening to spill into Rwanda, a new study suggests that an existing, FDA-approved drug called nitazoxanide could potentially help contain this deadly, highly contagious infection. In meticulous experiments in human cells, led by Boston Children’s Hospital, the drug significantly amplified immune responses to Ebola and inhibited Ebola replication.
The study, published in the Cell Press journal iScience, also showed how the drug works: It enhances the immune system’s ability to detect Ebola, normally impeded by the virus.
Nitazoxanide, or NTZ, is currently used to treat gastrointestinal infections caused by parasites such as Giardia and Cryptosporidium. It has been shown to be safe and even comes in a formulation for children. Study leader Anne Goldfeld, MD, of the Program in Cellular and Molecular Medicine at Boston Children’s, hopes that, with further testing and validation, it could be part of the solution for Ebola.
“Currently, there is no easily deployable therapy for Ebola virus,” she says. “There are some very promising vaccines, but there is no oral, inexpensive medication available.”
The Ebola virus caused more than 10,000 deaths in the 2014-2016 West African epidemic and more than 1,800 lives (as of August 6th) in the current outbreak in the Democratic Republic of the Congo. The virus is very good at evading human immune defenses. Though very small, it has two genes devoted to blocking immune responses.
Goldfeld and collaborators Chad Mire, PhD and Thomas Geisbert, PhD at the University of Texas Medical Branch, Galveston, showed in Biosafety Level 4 laboratory experiments that NTZ inhibits the Ebola virus (isolated from an earlier outbreak). Additional experiments performed in collaboration with Sun Hur, PhD of Boston Children’s showed that NTZ works by broadly amplifying the interferon pathway and cellular viral sensors, including two known as RIG-I and PKR. By deleting RIG-I and PKR in human cells through CRISPR editing, Goldfeld and University of Texas colleagues showed that NTZ works through these molecules to inhibit Ebola virus.
“Ebola masks RIG-I and PKR, so that cells don’t perceive that Ebola is inside,” explains Goldfeld. “This lets Ebola get a foothold in the cell and race ahead of the immune response. What we’ve been able to do is enhance the host viral detection response with NTZ. It’s a new path in treating Ebola.”
Goldfeld hopes to move into animal studies soon, especially given that NTZ has already been used in millions of people with minimal side effects. If effective, it could thus be easily repurposed for Ebola treatment or prevention.
The Latest on: Ebola
via Google News
The Latest on: Ebola
- Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize Impacton October 7, 2020 at 2:45 pm
Download As researchers who have long experience with HIV/AIDS prevention, vaccines, and therapies, some of whom also have experience with Ebola, we believe it is critical to build the response to the ...
- NYC Ebola Doctor Who Trump Blasted 6 Years Ago Fires Back Over Risk of Spreading Viruson October 6, 2020 at 5:13 am
The NYC emergency room physician who survived Ebola in 2014 -- and who then-private citizen Donald Trump blasted for being selfish -- is firing back now that Trump is the president and the one with a ...
- Six years ago, Trump blasted an Ebola-infected doctor. Now he’s hitting back over the president’s coronavirus actions.on October 6, 2020 at 3:49 am
At a time when the president has said that people should not be afraid of an illness that has already killed more than 209,000 Americans, commentators on Monday pointed to his 2014 critique of Spencer ...
- USF researcher using lessons from Ebola in hopes of tracking COVID-19 trajectoryon October 5, 2020 at 8:45 pm
A researcher with the University of South Florida is working to apply methods used to study the Ebola virus outbreaks to look at the spread of the virus causing COVID-19.
- Resurfaced Ebola tweets show that Trump has ignored his own adviceon October 5, 2020 at 2:11 pm
Now Trump’s 2014 tweets about Ebola are casting his pre- and post-diagnosis behavior in what some view as an extremely hypocritical light. In 2014, he repeatedly blamed President Barack Obama for ...
- A Doctor Who’s Fought Ebola And Other Epidemics On Handling The White House Coronavirus Outbreakon October 5, 2020 at 1:16 am
Dr. Mark Kortepeter, who’s fought epidemics on multiple continents, explains what the government needs to do right now to combat the Covid-19 outbreak that’s struck the White House.
- Method used to track Ebola's trajectory being applied to COVID-19on October 5, 2020 at 12:49 am
What exactly happened in Asia that caused SARS-CoV-2 to rapidly spread across the region and then essentially came to a halt there? That's what researchers from the University of South Florida are ...
- WHO 'outraged' by sex abuse reports in Congo Ebola operationon October 2, 2020 at 9:40 am
The World Health Organization (WHO) promised an investigation on Friday into "horrific" allegations of sexual abuse by aid workers combating an Ebola outbreak in Democratic Republic of Congo. "To be ...
- 'God chose me': Congo Ebola survivor finds new purposeon October 1, 2020 at 1:40 pm
For Esperance Nyabintu, catching Ebola was a curse and a gift from God. A year ago the virus killed her husband. Most of her neighbours, friends and family abandoned her, such is the social stigma of ...
- Ex-Obama official on the 'most troubling' difference between Ebola and COVID responseson September 30, 2020 at 7:15 am
The “most troubling” difference between the U.S. response to the Ebola pandemic and its handling of the coronavirus is the nation’s failure to lead a coordinated global effort to tackle the virus, ...
via Bing News